November 29, 2021

The World Stock Markets Tips & Targets, News, Views & Updates

The World Stock Markets Tips & Targets, News, Views & Updates

Zydus Cadila likely to launch Covid-19 vaccine ZyCoV-D next month

India’s fourth Covid-19 vaccine is likely to be available next month as sources say Cadila Healthcare’s ZyCoV-D, the world’s first plasmid DNA vaccine, will be launched in December. The launch may pave the way for Covid-19 jabs for adolescents as the vaccine is approved for use in children aged 12 years and above.

The company did not wish to comment. Cadila Healthcare (Zydus Cadila) had said in the first week of November it had received an order to supply 10 million doses of ZyCoV-D to the Centre. The vaccine has been priced at Rs 265 per dose and the needle-free applicator is being offered at Rs 93 a dose, excluding goods and services tax (GST).

Sources say vaccinations for children may start in January. “It is likely to start with co-morbid and vulnerable children in January, and by March, it is likely to be made open for all children,” a source in the know said.

Meanwhile, Zydus is working with a Korean partner to commercialise ZyCoV-D in South Korea in 2022. Zydus will provide manufacturing licences and transfer the plasmid DNA vaccine technology to Enzychem Lifesciences. Enzychem will make 80 million doses of the vaccine in 2022 and some of this production could come to India, a source said.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Share This :